Roche’s ALK inhibitor Alecensa receives FDA approval to treat early-stage NSCLC
Approximately half of all patients with early lung cancer experience cancer recurrence following surgery
Approximately half of all patients with early lung cancer experience cancer recurrence following surgery
The Paddington site will serve as one of the company’s three global hubs
The selected candidate can be developed as a monotherapy, combination therapy or both
Approximately half of all patients with early lung cancer experience cancer recurrence following surgery
The rare neurotrophic virus is responsible for an estimated 59,000 global deaths every year
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Apr 17, 2024 | Appointments
Dunford recently served as executive creative director at TBWA\WorldHealth
Read MoreApr 5, 2024 | Appointments
Colucci previously served as chief executive officer and chairman of Publicis Health
Read MoreMar 28, 2024 | Appointments
Mangan joins from 90TEN, where she most recently served as managing director
Read MoreMar 22, 2024 | Appointments
Pfister has most recently been serving as senior executive and London hub lead at the company
Read MoreApr 19, 2024 | Intelligence
Industry is urged to ditch the simple slogans and instead embrace the complexity, as delving more deeply could improve success rates
Read MoreApr 18, 2024 | Intelligence
PME spoke to Marci English, Vice President and Head of BioPharma Development, Astellas, about the importance of new treatments for menopause symptoms, the unmet need and the company’s commitment to midlife women’s health
Read MoreApr 10, 2024 | Intelligence
Expert strategists ask four crucial questions – the first one confounds most of us
Read MoreApr 8, 2024 | Intelligence
PME spoke to Remi Turbet Delof from Systech about his work with customers to help them navigate the complex world of serialisation
Read MoreApr 4, 2024 | Intelligence
In the face of the increasing threat from AMR, the recent Bioinfect 2024 conference offers five reasons to be hopeful
Read MoreApr 2, 2024 | Intelligence
Optimising MS care and patient outcomes through advancing shared decision-making
Read MoreApril 17, 2024 | Research Partnership|
Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.
April 16, 2024 | Wallace Health|B Corp, ethical marketing, social and environmental impact
Going through the B Corp process – and successfully gaining certification at the end of last year – gave us a stronger sense of our …
April 16, 2024 | Medscape Education Global|Leadership, Women in healthcare, healthcare
Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is …
April 15, 2024 | Research Partnership|Brand Strategy, Connected Solutions, Customer Engagement, market research
The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were …
April 11, 2024 | Medscape Education Global|
The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this …
April 17, 2024 | Mednet Group|Stress Awareness Month
Explore how we’re supporting our team with managing stress in the workplace
April 11, 2024 | Research Partnership|
The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective …
April 9, 2024 | Mtech Access|
The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come …
April 4, 2024 | Mednet Group|Diversity and Inclusion, neurodiversity, thought leadership
Find out more about autism and how we’re supporting autistic people in the workplace
April 2, 2024 | Research Partnership|Avatars, Healthcare Market Research, Innovation, artificial intelligence
Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market …
April 18, 2024 | Impetus Digital | Asynchronous touchpoints, DOL engagement, HCP engagement, KOL Engagement, MSL engagement, Pharma engagement, Virtual Pharma, Virtual advisory board, digital advisory board, pharma innovation, pharma virtual meeting
Account Specialist - Respiratory - Kent & Medway
Market Access Business Manager - Advanced Wound Care - North
Key Account Manager - Urology - East Anglia, Beds & Bucks
Therapy Development Specialist - Greater London & East Anglia